Pain Management Devices Market

The report "Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029", is projected to reach USD 5,835.8 million by 2029 from USD 3,768.6 million in 2024, at a CAGR of 9.1% during the forecast period.

Browse 294 market data Tables and 64 Figures spread through 297 Pages and in-depth TOC on "Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html

Globally, the growing burden of chronic pain conditions, growing number of surgical procedure performed and rising aging population  globally are anticipated to accelerate the demand for pain management devices, further propelling the adoption of pain management devices products . Moreover, the growing focus on advanced devices and government initiative to aid affordibility and accessibility are likely to fuel the market growth. Moreover, the increasing investments for new product development and growing  adoption pain management devices in home care settings owing to its advantages are expecetd to support  the pain management devices market growth during the forecast period.

High procedural cost, and increasing product recalls are likely to hamper the growth of pain management devices market

The neurostimulation devices segment, is expected to register the largest market share and highest growth rate of the global pain management devices market  in 2023.

The pain management devices market is segmented into neurostimulation devices, infusion pumps and ablation devices based on type. The neurostimulation devices segment is anticipated to register the highest share and higher growth rate in the pain management devices market. Due to the large number of ongoing clinical studies to establish the efficacy and safety of these devices in pain management, new product launches & approvals and the increasing prevalence of chronic pain conditions. In addition, the advantages of neurostimulation as compared to alternative therapies for managing chronic pain are further propelling its market growth.

The home care settings is anticipated to grow at a significant rate in the pain management devices market in 2023.

The pain management devices market is segmented into hospitals & clinics, physiotherapy centers, home care settings and other end users based on end user. In 2023, the home care settings segment is growing at a faster pace. The demand for pain management devices in home care is rising as patients seek effective, convenient treatments at home and reduced hospital stays. Advances in technology have made portable devices, like infusion pumps and wearable stimulators, more accessible, offering personalized care and improving quality of life. All these factors are driving the increasing use of pain management devices in home care settings.

“The Asia pacific market, by region, to register highest growth rate in the forecast period.”

The pain management devices market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa based on region.  The Asia Pacific market is likely to witness significant market growth. This is attribute to the rise in geriatric patient population, increasing cases of chronic diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility pain management devices products. All these factors contributing to higher growth rate of pain devices market in this region.

As of 2023, pain management devices market was dominated by Medtronic  (Ireland), Boston Scientific  Corporation(US), Abbott Laboratories (US), Stryker (US), Nevro Corp. (US),  Becton, Dickinson and Company (US), Baxter (US), B. Braun SE  (Germany), Omron Corporation (Japan) , among others.

Don’t miss out on business opportunities in Pain Management Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]